The Motley Fool

Bitcoin’s tipped to end 2019 at $12,000! I’d still rather buy these FTSE 100 dividend stocks

What a weekend Bitcoin and its investors enjoyed! Up 25% since 9am on Friday and trading barging through $10,000 at one point before settling at current levels around $9,400. And encouraged by these heady gains, there’s plenty of experts putting their heads above the parapet to predict big things for the next few months and beyond.

One such Bitcoin bull is Nigel Green of financial advisory firm deVere Group. He predicts the virtual currency will soar to $12,000 by the close of the year, provided it can avoid the ‘Death Cross’ this week.

Sign up for FREE issues of The Motley Fool Collective. Do you want straightforward views on what’s happening with the stock market, direct to your inbox? Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio. Click here to get started now — it’s FREE!

In technical terms, this is “a bearish pattern that takes place when the 50-day moving average falls below the 200-day moving average.” In layman’s terms, this key level is around the $8,500 marker, a point at which the crypto asset has previously enjoyed strong support, Green says.

China chips in

So why exactly is the deVere chief exec so positive, you may ask? Well, in a word, China. Late last week, president Xi claimed the country should “seize the opportunity” to adopt blockchain and lauded the next-gen technology as “an important breakthrough for independent innovation of core technologies.”

According to Green: “This is a clear signal that the leader of the world’s second-largest economy is moving towards embracing the technology — in which Bitcoin plays a vital part — and therefore taken as a positive boost for the whole digital currencies sector.

It also comes as China is said to be developing its own national digital currency, which is further proof that in some form or another, digital currency is the future,” he adds.

Bitcoin clearly has the bit between its teeth and there are other factors, like fears over the slowing global economy and political issues, such as Brexit and the US-Chinese trade war, which could boost buying in the weeks and months to come, Green predicts. He suggests that FOMO — or the ‘Fear of Missing Out’ — could also continue to drive investor demand.

Better buys

I don’t want to be a party pooper, but I’m afraid these latest price rises do little to raise my enthusiasm for crypto assets. In fact, the wild volatility of recent days illustrates exactly why I consider Bitcoin and similar currencies to be unsuitable investment destinations, and particularly so as a wide range of questions over the legitimacy of this asset class remain unanswered.

Why take a gamble with your money on an asset where prices will likely continue to swing lower and lower? I’d much rather plough my hard-earned capital into FTSE 100 dividend stocks, investments which have proven to be much more stable, and over a longer period of time too.

While the geopolitical and macroeconomic environment could indeed boost safe-haven demand for Bitcoin now and during 2020, I’d much rather buy classic defensive stocks such as defence giant BAE Systems, healthcare specialist GlaxoSmithKline, telecoms titan Vodafone, or power network operator National Grid. Right now, share pickers can grab a mighty, inflation-bashing average yield of 4.8%, and I reckon this makes the blue-chips (broadly speaking) brilliant buys today.

You Really Could Make A Million

Of course, picking the right shares and the strategy to be successful in the stock market isn't easy. But you can get ahead of the herd by reading the Motley Fool's FREE guide, “10 Steps To Making A Million In The Market”.

The Motley Fool's experts show how a seven-figure-sum stock portfolio is within the reach of many ordinary investors in this straightforward step-by-step guide.

Simply click here for your free copy.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.